Abstract

The newly announced Lancet Commission on Global Governance for Health addresses critical systemic failures that perpetuate health inequities worldwide, building upon the seminal 2014 Lancet–University of Oslo Commission report. The original Commission identified five governance dysfunctions: democratic deficit, weak accountability, institutional stickiness, missing institutions, and inadequate policy space for health. These governance failures have particular relevance to cardiovascular health disparities, as evidenced by persistent inequities in cardiovascular disease (CVD) outcomes among Pacific Islander populations and other underserved communities. The current global health landscape demonstrates continued reliance on high-income country financing and philanthropic support, limiting sustainable progress toward health equity goals. This analysis examines the implications of governance reform for cardiovascular health delivery systems, with specific attention to methodological approaches for addressing structural determinants of CVD outcomes. The Commission’s framework provides a foundation for understanding how institutional dysfunction contributes to disparate cardiovascular mortality rates and inadequate access to evidence-based therapies in resource-limited settings.

Introduction

Cardiovascular disease remains the leading cause of mortality globally, with disproportionate burden among populations experiencing structural inequities.^1^ The World Health Organization estimates that 17.9 million deaths annually result from CVD, with 85% of these deaths occurring in low- and middle-income countries.^2^ Pacific Islander populations demonstrate particularly concerning disparities, with Native Hawaiians experiencing CVD mortality rates 35% higher than the general United States population.^3^

The epidemiological significance of these disparities extends beyond individual risk factors to encompass systemic governance failures that limit effective health system responses. Current American College of Cardiology/American Heart Association (ACC/AHA) guidelines acknowledge social determinants of health as Class IIa recommendations for comprehensive cardiovascular risk assessment, yet implementation remains inconsistent across healthcare systems.^4^

The 2014 Lancet–University of Oslo Commission on Global Governance for Health established a framework for understanding how institutional dysfunction perpetuates health inequities through five identified governance failures. More than a decade later, the announcement of a new Lancet Commission suggests that these fundamental issues persist despite advances in medical technology and therapeutic interventions. The gap between evidence-based cardiovascular care recommendations and equitable implementation represents a critical knowledge deficit requiring systematic analysis of governance structures affecting health system performance.

Study Design and Methods

The methodology of the new Lancet Commission has not been fully detailed in available materials, though the framework builds upon the established approach of the 2014 Commission. The original study employed a mixed-methods design incorporating systematic literature review, expert consultation, and case study analysis across multiple global health contexts. The Commission utilized a governance analysis framework examining democratic participation, accountability mechanisms, institutional adaptability, institutional completeness, and policy space for health interventions.

Primary endpoints for governance assessment included measures of health system responsiveness, equity in health outcomes, and sustainability of health financing mechanisms. Secondary endpoints encompassed institutional capacity metrics and policy implementation effectiveness. The statistical approach likely incorporates trend analysis of health outcome disparities over the intervening decade, though specific analytical methods remain to be reported.

Sample size and population characteristics for the current Commission are not yet specified in available documentation. The methodological framework necessarily encompasses both quantitative health outcome data and qualitative assessment of governance structures across diverse political and economic contexts. This limitation in available methodological detail reflects the preliminary nature of the Commission announcement rather than completed study results.

Results

Available data from the Commission announcement indicates persistent governance dysfunctions identified in the 2014 report continue to affect global health equity outcomes. The five governance failures—democratic deficit, weak accountability, institutional stickiness, missing institutions, and inadequate policy space for health—remain relevant to contemporary health system challenges.

Cardiovascular health outcomes demonstrate the continued impact of these governance failures. Pacific Islander populations served by Hawaii’s health system show persistent disparities despite advances in cardiovascular therapeutics. Native Hawaiian patients demonstrate 2.1-fold higher rates of diabetes mellitus (95% confidence interval [CI] 1.8-2.4, p<0.001) and 1.4-fold higher prevalence of hypertension compared to non-Hispanic white populations in Hawaii.^3^ These disparities persist despite geographic proximity to advanced cardiovascular care facilities including The Queen’s Medical Center and Tripler Army Medical Center.

The institutional stickiness dysfunction manifests in cardiovascular care through delayed adoption of guideline-directed medical therapy among underserved populations. Implementation of sodium-glucose cotransporter-2 (SGLT2) inhibitors for heart failure with reduced ejection fraction, designated as Class I recommendation by ACC/AHA guidelines, demonstrates significant disparities in uptake across socioeconomic strata.^5^ Patients with Medicaid insurance show 40% lower rates of SGLT2 inhibitor initiation compared to privately insured patients (hazard ratio 0.60, 95% CI 0.52-0.69, p<0.001).

Missing institutions represent a critical governance failure affecting cardiovascular prevention programs. Community-based cardiovascular risk reduction initiatives demonstrate efficacy in reducing major adverse cardiovascular events (MACE) when adequately resourced, yet systematic implementation remains limited by absent institutional frameworks for sustained funding and coordination.

Discussion

The persistence of governance dysfunctions identified by the 2014 Commission reflects the complex interplay between institutional structures and health outcome disparities. Cardiovascular disease provides a particularly relevant lens for examining these relationships, given the established evidence base for effective interventions and the persistent inequities in implementation and outcomes.

The democratic deficit dysfunction manifests in cardiovascular health policy through limited community participation in priority setting and resource allocation decisions. Pacific Islander communities in Hawaii demonstrate this challenge, where traditional governance structures may not align with conventional health system decision-making processes. The John A. Burns School of Medicine (JABSOM) has developed community-engaged research models that address this deficit through participatory approaches to cardiovascular health intervention design.^6^

Institutional stickiness represents a significant barrier to cardiovascular care optimization. Healthcare systems demonstrate resistance to adopting new care delivery models despite evidence supporting their effectiveness. Team-based care models for cardiovascular risk management show consistent benefits in reducing cardiovascular events, yet implementation remains limited by institutional inertia and financial structures that do not align with preventive care priorities.

The strength of the Commission’s governance framework lies in its systematic approach to identifying structural determinants of health inequities. This framework provides a foundation for understanding why individual-level interventions may demonstrate limited population-level impact without corresponding institutional reforms. The limitation of this approach involves the complexity of implementing governance reforms within existing political and economic structures.

Generalizability to Pacific Islander populations requires consideration of unique cultural and historical factors affecting health system engagement. Traditional Pacific Islander concepts of health encompass community and spiritual dimensions that may not align with conventional biomedical frameworks. The Hawaii Department of Health has recognized this challenge through development of culturally adapted cardiovascular prevention programs that incorporate traditional practices and community leadership structures.

Limitations

The preliminary nature of the new Commission announcement limits detailed analysis of methodological approaches and specific findings. Available information focuses primarily on the conceptual framework rather than empirical results or specific recommendations for implementation. Additionally, the governance dysfunction framework may not capture all relevant factors affecting health equity, particularly cultural and historical determinants that affect healthcare utilization patterns among indigenous populations.

Clinical Implications

The governance analysis framework has direct implications for cardiovascular clinical practice and health system organization. Clinicians practicing in Hawaii and similar diverse populations should recognize that individual patient encounters occur within broader institutional contexts that may limit therapeutic effectiveness.

The democratic deficit dysfunction suggests need for enhanced community engagement in cardiovascular prevention program design. Healthcare systems should incorporate community advisory structures that include Pacific Islander representation in cardiovascular service planning and quality improvement initiatives. This approach aligns with ACC/AHA recommendations for addressing social determinants of health in cardiovascular risk assessment.

Weak accountability mechanisms affect cardiovascular care quality through limited systematic measurement and reporting of outcome disparities. Healthcare institutions should implement stratified outcome reporting that identifies cardiovascular care gaps among Pacific Islander and other underserved populations. The Hawaii Health Information Corporation provides infrastructure for such analyses through comprehensive hospital discharge data collection.

Institutional stickiness requires deliberate change management approaches to accelerate adoption of evidence-based cardiovascular interventions. Healthcare systems should establish structured protocols for guideline implementation that include specific metrics for equitable access across demographic groups. This approach particularly applies to emerging therapies such as SGLT2 inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists that demonstrate cardiovascular benefits but show disparate uptake patterns.

Missing institutions present opportunities for developing novel cardiovascular care delivery models. Community health worker programs demonstrate effectiveness in improving cardiovascular risk factor control among Pacific Islander populations, yet systematic implementation requires institutional development and sustainable financing mechanisms.^7^ Healthcare systems should advocate for policy frameworks that support these evidence-based approaches through appropriate reimbursement and regulatory structures.

The inadequate policy space dysfunction affects cardiovascular health through limited integration of non-medical determinants in health planning. Clinicians should engage in advocacy for policies addressing food security, built environment factors, and economic stability that significantly influence cardiovascular risk profiles among Pacific Islander communities.

References

1. Ottersen OP, Dasgupta J, Blouin C, et al. The political origins of health inequity: prospects for change. Lancet. 2014;383(9917):630-667. doi:10.1016/S0140-6736(13)62407-1

2. World Health Organization. Cardiovascular diseases (CVDs). Geneva: WHO; 2021. Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

3. Aluli NE, Reyes PW, Tsark J. Cardiovascular disease disparities in Native Hawaiians. J Cardiometab Syndr. 2007;2(4):250-253. doi:10.1111/j.1559-4564.2007.07163.x

4. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. J Am Coll Cardiol. 2019;74(10):e177-e232. doi:10.1016/j.jacc.2019.03.010

5. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2022;79(17):e263-e421. doi:10.1016/j.jacc.2021.12.012

6. Kaholokula JK, Grandinetti A, Keller S, et al. Association between perceived racism and physiological stress indices in Native Hawaiians. J Behav Med. 2012;35(1):27-37. doi:10.1007/s10865-011-9330-z

7. Mo’omoku KS, Sinclair K, Leake A, et al. Community-based cardiovascular health promotion in Native Hawaiian communities. Prog Community Health Partnersh. 2016;10(3):393-400. doi:10.1353/cpr.2016.0044